These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 7825228)

  • 1. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update.
    Capron A; Riveau G; Grzych JM; Boulanger D; Capron M; Pierce R
    Trop Geogr Med; 1994; 46(4 Spec No):242-6. PubMed ID: 7825228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update.
    Capron A; Riveau G; Grzych JM; Boulanger D; Capron M; Pierce R
    Mem Inst Oswaldo Cruz; 1995; 90(2):235-40. PubMed ID: 8531664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of defined antigen vaccines against Schistosoma bovis and S. japonicum in bovines.
    Bashir M; Bickle Q; Bushara H; Cook L; Shi F; He D; Huggins M; Lin J; Malik K; Moloney A
    Trop Geogr Med; 1994; 46(4 Spec No):255-8. PubMed ID: 7825230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine strategies against schistosomiasis.
    Capron A; Dessaint JP; Capron M; Pierce RJ
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():1-9. PubMed ID: 1342702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA antibodies to a protective antigen in human Schistosomiasis mansoni.
    Grzych JM; Grezel D; Xu CB; Neyrinck JL; Capron M; Ouma JH; Butterworth AE; Capron A
    J Immunol; 1993 Jan; 150(2):527-35. PubMed ID: 8419485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosoma mansoni 28-kDa glutathione S-transferase and immunity against parasite fecundity and egg viability. Role of the amino- and carboxyl-terminal domains.
    Xu CB; Verwaerde C; Gras-Masse H; Fontaine J; Bossus M; Trottein F; Wolowczuk I; Tartar A; Capron A
    J Immunol; 1993 Feb; 150(3):940-9. PubMed ID: 8423348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosomiasis vaccines: Farewell to the God of Plague?
    Taylor MG
    J Trop Med Hyg; 1994 Oct; 97(5):257-68. PubMed ID: 7932921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
    Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C
    J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody blocking the Schistosoma mansoni 28-kDa glutathione S-transferase activity reduces female worm fecundity and egg viability.
    Xu CB; Verwaerde C; Grzych JM; Fontaine J; Capron A
    Eur J Immunol; 1991 Aug; 21(8):1801-7. PubMed ID: 1868871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies.
    Grezel D; Capron M; Grzych JM; Fontaine J; Lecocq JP; Capron A
    Eur J Immunol; 1993 Feb; 23(2):454-60. PubMed ID: 8436179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic aspects of schistosomiasis.
    Capron A; Dessaint JP
    Annu Rev Med; 1992; 43():209-18. PubMed ID: 1580585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials.
    Capron A; Riveau G; Capron M; Trottein F
    Trends Parasitol; 2005 Mar; 21(3):143-9. PubMed ID: 15734662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of the protective immunity to Schistosoma japonicum in Chinese yellow cattle induced by recombinant 26kDa glutathione-S-transferase (reSjc26GST).
    Wu Z; Liu S; Zhang S; Tong H; Gao Z; Liu Y; Lin D; Liu Z; Wu G; Yi H; Song G; Xu Y
    Vet Parasitol; 2004 Sep; 123(3-4):167-77. PubMed ID: 15325043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of Schistosoma bovis egg production in cattle by vaccination with either glutathione S-transferase or keyhole limpet haemocyanin.
    Bushara HO; Bashir ME; Malik KH; Mukhtar MM; Trottein F; Capron A; Taylor MG
    Parasite Immunol; 1993 Jul; 15(7):383-90. PubMed ID: 8414642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and future prospects for a vaccine against schistosomiasis.
    Lebens M; Sun JB; Czerkinsky C; Holmgren J
    Expert Rev Vaccines; 2004 Jun; 3(3):315-28. PubMed ID: 15176948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis.
    Balloul JM; Grzych JM; Pierce RJ; Capron A
    J Immunol; 1987 May; 138(10):3448-53. PubMed ID: 3106483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccine against bilharziasis. Strategies and perspectives].
    Capron A
    Rev Prat; 1993 Feb; 43(4):457-61. PubMed ID: 8341911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine strategies against schistosomiasis: from concepts to clinical trials.
    Capron A; Capron M; Dombrowicz D; Riveau G
    Int Arch Allergy Immunol; 2001; 124(1-3):9-15. PubMed ID: 11306914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters of the attenuated schistosome vaccine evaluated in the olive baboon.
    Kariuki TM; Farah IO; Yole DS; Mwenda JM; Van Dam GJ; Deelder AM; Wilson RA; Coulson PS
    Infect Immun; 2004 Sep; 72(9):5526-9. PubMed ID: 15322059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.